Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia.

Malesci A, Basso G, Bianchi P, Fini L, Grizzi F, Celesti G, Di Caro G, Delconte G, Dattola F, Repici A, Roncalli M, Montorsi M, Laghi L.

Br J Cancer. 2014 Mar 4;110(5):1228-35. doi: 10.1038/bjc.2013.827.

2.

Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.

Seppälä TT, Böhm JP, Friman M, Lahtinen L, Väyrynen VM, Liipo TK, Ristimäki AP, Kairaluoma MV, Kellokumpu IH, Kuopio TH, Mecklin JP.

Br J Cancer. 2015 Jun 9;112(12):1966-75. doi: 10.1038/bjc.2015.160.

3.

Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.

Ooki A, Akagi K, Yatsuoka T, Asayama M, Hara H, Takahashi A, Kakuta M, Nishimura Y, Yamaguchi K.

J Surg Oncol. 2014 Dec;110(8):982-8. doi: 10.1002/jso.23755.

PMID:
25154726
4.

Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis.

Hughes LA, Williamson EJ, van Engeland M, Jenkins MA, Giles GG, Hopper JL, Southey MC, Young JP, Buchanan DD, Walsh MD, van den Brandt PA, Alexandra Goldbohm R, Weijenberg MP, English DR.

Int J Epidemiol. 2012 Aug;41(4):1060-72.

PMID:
22531127
5.

Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study.

Wish TA, Hyde AJ, Parfrey PS, Green JS, Younghusband HB, Simms MI, Fontaine DG, Dicks EL, Stuckless SN, Gallinger S, McLaughlin JR, Woods MO, Green RC.

Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1831-9. doi: 10.1158/1055-9965.EPI-10-0055.

6.

BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?

Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, Carneiro F, Oliveira C, Seruca R.

BMC Cancer. 2008 Sep 9;8:255. doi: 10.1186/1471-2407-8-255.

7.

Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma.

de Maat MF, Narita N, Benard A, Yoshimura T, Kuo C, Tollenaar RA, de Miranda NF, Turner RR, van de Velde CJ, Morreau H, Hoon DS.

Am J Pathol. 2010 Nov;177(5):2347-56. doi: 10.2353/ajpath.2010.091103.

8.

Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.

Fujiyoshi K, Yamamoto G, Takenoya T, Takahashi A, Arai Y, Yamada M, Kakuta M, Yamaguchi K, Akagi Y, Nishimura Y, Sakamoto H, Akagi K.

Anticancer Res. 2017 Jan;37(1):239-247.

PMID:
28011498
9.

High-frequency microsatellite instability and BRAF mutation (V600E) in unselected Serbian patients with colorectal cancer.

Markovic S, Antic J, Dragicevic N, Hamelin R, Krivokapic Z.

J Mol Histol. 2012 Apr;43(2):137-43. doi: 10.1007/s10735-011-9387-6.

PMID:
22210186
10.

Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.

Zlobec I, Kovac M, Erzberger P, Molinari F, Bihl MP, Rufle A, Foerster A, Frattini M, Terracciano L, Heinimann K, Lugli A.

Int J Cancer. 2010 Dec 1;127(11):2569-75. doi: 10.1002/ijc.25265.

11.

BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics.

Phipps AI, Buchanan DD, Makar KW, Burnett-Hartman AN, Coghill AE, Passarelli MN, Baron JA, Ahnen DJ, Win AK, Potter JD, Newcomb PA.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1792-8. doi: 10.1158/1055-9965.EPI-12-0674.

12.

Relationship between genetic alterations and prognosis in sporadic colorectal cancer.

Chang SC, Lin JK, Yang SH, Wang HS, Li AF, Chi CW.

Int J Cancer. 2006 Apr 1;118(7):1721-7.

13.

Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.

de Cuba EM, Snaebjornsson P, Heideman DA, van Grieken NC, Bosch LJ, Fijneman RJ, Belt E, Bril H, Stockmann HB, Hooijberg E, Punt CJ, Koopman M, Nagtegaal ID, Coupé VH, Carvalho B, Meijer GA.

Int J Cancer. 2016 Mar 1;138(5):1139-45. doi: 10.1002/ijc.29855.

14.

Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.

Oliveira C, Velho S, Domingo E, Preto A, Hofstra RM, Hamelin R, Yamamoto H, Seruca R, Schwartz S Jr.

Oncogene. 2005 Nov 17;24(51):7630-4.

PMID:
16007118
15.

Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).

Goldstein J, Tran B, Ensor J, Gibbs P, Wong HL, Wong SF, Vilar E, Tie J, Broaddus R, Kopetz S, Desai J, Overman MJ.

Ann Oncol. 2014 May;25(5):1032-8. doi: 10.1093/annonc/mdu100.

16.

Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers.

Bond CE, Umapathy A, Buttenshaw RL, Wockner L, Leggett BA, Whitehall VL.

PLoS One. 2012;7(10):e47483. doi: 10.1371/journal.pone.0047483.

17.

Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.

Inamura K, Yamauchi M, Nishihara R, Lochhead P, Qian ZR, Kuchiba A, Kim SA, Mima K, Sukawa Y, Jung S, Zhang X, Wu K, Cho E, Chan AT, Meyerhardt JA, Harris CC, Fuchs CS, Ogino S.

J Natl Cancer Inst. 2014 Sep 4;106(9). pii: dju195. doi: 10.1093/jnci/dju195.

18.

Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma.

Wright CM, Dent OF, Newland RC, Barker M, Chapuis PH, Bokey EL, Young JP, Leggett BA, Jass JR, Macdonald GA.

Gut. 2005 Jan;54(1):103-8.

19.

Microsatellite stable colorectal cancers stratified by the BRAF V600E mutation show distinct patterns of chromosomal instability.

Bond CE, Nancarrow DJ, Wockner LF, Wallace L, Montgomery GW, Leggett BA, Whitehall VL.

PLoS One. 2014 Mar 20;9(3):e91739. doi: 10.1371/journal.pone.0091739.

20.

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer.

Tran B, Kopetz S, Tie J, Gibbs P, Jiang ZQ, Lieu CH, Agarwal A, Maru DM, Sieber O, Desai J.

Cancer. 2011 Oct 15;117(20):4623-32. doi: 10.1002/cncr.26086.

Supplemental Content

Support Center